73 related articles for article (PubMed ID: 1706010)
1. Sustained-release diltiazem and prevention of cardiovascular risk in hypertensive patients.
Djian J
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S20-7. PubMed ID: 1706010
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
[TBL] [Abstract][Full Text] [Related]
4. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
5. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
[TBL] [Abstract][Full Text] [Related]
7. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
Oparil S; Bakir SE
Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
[TBL] [Abstract][Full Text] [Related]
8. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacology--new therapy. Calcium channel blockers: new aspects of therapeutic use of diltiazem].
Beleslin DB; Prostran MS; Jovanović-Mićić D
Srp Arh Celok Lek; 1992; 120(5-6):188-92. PubMed ID: 1465675
[TBL] [Abstract][Full Text] [Related]
10. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
Lueg MC; Herron J; Zellner S
Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
[TBL] [Abstract][Full Text] [Related]
11. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
14. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
Weir RJ; Lee PS; Clegg DS; Hemingray S; Belgrave GP; Walter E
Br J Clin Pract; 1994; 48(6):287-92. PubMed ID: 7848788
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
Applegate W; Cohen JD; Wolfson P; Davis A; Green S
Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
[TBL] [Abstract][Full Text] [Related]
16. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
[TBL] [Abstract][Full Text] [Related]
17. Arterial vasodilator and antihypertensive effects of diltiazem.
Kiowski W; Linder L; Bühler FR
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S7-10. PubMed ID: 1707118
[TBL] [Abstract][Full Text] [Related]
18. Treatment of arterial hypertension in the elderly with diltiazem vs ramipril.
Terranova R; Luca S
Minerva Cardioangiol; 2000 Jun; 48(6):183-96. PubMed ID: 11048472
[TBL] [Abstract][Full Text] [Related]
19. Trial of slow release diltiazem for essential hypertension in general practice.
Coulter DM
N Z Med J; 1991 Feb; 104(905):37-8. PubMed ID: 1996187
[TBL] [Abstract][Full Text] [Related]
20. Development and pharmacokinetics of a new sustained-release formulation of diltiazem.
Thiercelin JF; Necciari J; Caplain H; Cournot A; Combes M; Desmolin H; Flouvat B
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S31-7. PubMed ID: 1706011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
